| 1 |
34175815 | New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. | 2021 Sep |
1 |
| 2 |
30771618 | TFAP2C-Activated MALAT1 Modulates the Chemoresistance of Docetaxel-Resistant Lung Adenocarcinoma Cells. | 2019 Mar 1 |
2 |
| 3 |
30880686 | The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines. | 2019 Sep-Oct |
7 |
| 4 |
29102917 | miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1. | 2018 Jan |
7 |
| 5 |
28133913 | The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer. | 2017 Mar |
10 |
| 6 |
24659820 | Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer. | 2014 May |
1 |
| 7 |
23255418 | Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line. | 2013 Jun |
4 |